Cognitive impairment in individuals with major depressive disorder should be treated as a primary problem.
Your search for major depressive disorder returned 64 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Dr Amit Akirov examines the evidence suggesting associations between migraine and major depressive disorder (MDD).
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
Comorbid psychological conditions affect cognitive function in Parkinson’s disease, and treatment can be complicated by overlapping symptoms.
There is an emerging view that sleep disorders are not merely symptoms of psychiatric conditions; instead there may be a complex, bidirectional relationship between psychiatric and sleep disorders.
Combat veterans face an elevated risk of developing PTSD and comorbid depression, which severely affects quality of life.
People with migraines and comorbid mood disorders often need treatments that address both conditions, as well as management of sleep, stress, and lifestyle issues.
Common comorbidities in OSA such as cardiovascular disease and metabolic abnormalities, may confer a higher risk for the development of mental and cognitive impairment in patients with OSA compared with the general population.
Patients with depression can live with symptoms for a long period of time before finding an option that works. One possibility for patients who are unable to find relief through pharmacology is transcranial magnetic stimulation. An expert offers his view on this form of treatment.
Can mere light become a revolutionary new treatment for traumatic brain injury, posttraumatic stress disorder, depression, stroke, Parkinson disease, and Alzheimer disease?
Rates of HIV-associated dementia have decreased from approximately 50% in the pre-cART era to 2% currently. However, roughly 50% of patients treated with cART have the milder forms of HIV-associated neurocognitive disorder (HAND).
Authors of a paper share their perspectives on the topic of chronic pain in individuals with mental health disorders.
Responses to treatment depend on the target chosen, with 5 targets yielding positive outcomes, including the ventral anterior limb of the internal capsule, subthalamic nucleus, nucleus accumbens, ventral capsule/ventral striatum, or inferior thalamic peduncle, all involving fronto-striato-thalamocortical circuits.
Recent shifts in studies of sex and gender reiterate the critical need to tailor mental health care to each patient and to remain mindful about assumptions regarding sex and gender and their role in a given patient’s specific challenges.
Pseudobulbar affect is a significant national health issue in the United States, with approximately 2 million individuals affected.
SPECT imaging can be more accurate in the diagnosis of traumatic brain injury and post-traumatic stress disorder than CT or MRI.
There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.
This newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.
A personalized approach to treating epileptic seizures ensures a balance of effectiveness and tolerability for each patient.
Depression is one of the most commonly reported complications resulting from stroke.
Patients should be counseled on sleep hygiene before considering prescription sleep aides.
A survey of health care providers found a lack of knowledge on idiopathic hypersomnia (IH) among physicians, and that the disorder is often misdiagnosed. We spoke with Richard Bogan, MD, FCCP, FAASM, associate clinical professor at the University of the South Carolina School of Medicine about IH and criteria for diagnosing this sleep disorder.
In this review, study authors discuss and summarize the current evidence for the evaluation and management of the most prevalent and well-described conditions in SCI, including impact of SCI on sleep and daytime function.
Over 60% of people with Parkinson’s disease will have REM sleep behavior disorder, endangering them and their partners during the night.
In an interview, sleep medicine experts Milena K Pavlova, MD, and Rachel Ziegler, MD, discuss the latest developments in sleep disorder therapies and the existing gaps in sleep medicine.
A multi-faceted approach is best when treating pediatric headache.
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a disorder characterized by marked fatigue, exertion induced malaise, cognitive clouding (or brain fog), impaired academic/work performance, disrupted sleep, and joint/muscle pain.
Although compensating for their difficulties may help people with ASD connect with others, get jobs, and successfully navigate social situations, accumulating research suggests it can also lead to exhaustion, burnout, anxiety, and depression.
Debate continues as to whether ocular tremor represents a clinical marker of Parkinson’s disease or a compensatory movement related to other bodily tremors.